Immune Response of Haemodialysis Patients Post Covid-19 Vaccination

• Conditions: Immune Response Post Covid 19 Vaccination

• Registration Number: NCT04872751
• Lead Sponsor: Penang Hospital, Malaysia

Brief Summary

The purpose of this study is to assess immune response of end stage renal failure patients after Covid 19 vaccination

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-27
• Study First Submitted: 2021-04-29
• Status Verified: 2021-05
• Study First Submitted QC: 2021-05-02
• Study First Posted: 2021-05-04
• Last Update Submitted: 2021-05-04
• Last Update Posted: 2021-05-07
• Primary Completion: 2022-04
• Study Completion: 2022-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 425

Inclusion Criteria

• ESRF patient on hemodialysis who are eligible for the goverment Covid 19 vaccination programme
• 18 years old and above
• consented to join the study

Exclusion Criteria

• patient who refused to be vaccinated
• patient who deemed unsuitable for Covid vaccination

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change From Baseline in post vaccination SARS-CoV-2 neutralizing antibody level	up to one year	Study the antibody synthesis induced by vaccination, among end stage renal failure patients, and the change in its level at 1 month, at 6 months and at 1 year after complete vaccination.

Secondary Outcome Measures

Name	Time	Method
Change From Baseline in post vaccination SARS-CoV-2 neutralizing antibody level after 1st inoculation of the vaccine (incomplete vaccination)	one month	Study the antibody synthesis and the change in its level after 1st inoculation of the vaccine

Trial Locations

Locations (1)

Penang Hospital; 🇲🇾 George Town, Penang, Malaysia